Glucose-lowering effects of 7-day treatment with SGLT2 inhibitor confirmed by intermittently scanned continuous glucose monitoring in outpatients with type 1 diabetes. A pilot study
Authors:
- 2 January 2021
- journal article
- research article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 68 (3) , 361-369
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 22 references indexed in Scilit:
- Safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 1 diabetes: A systematic review and meta-analysisDiabetes Research and Clinical Practice, 2018
- Effects of Sotagliflozin Added to Insulin in Patients with Type 1 DiabetesNew England Journal of Medicine, 2017
- Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trialThe Lancet Diabetes & Endocrinology, 2017
- Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoringDiabetology & Metabolic Syndrome, 2017
- The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 DiabetesDiabetes Care, 2016
- SGLT2 Inhibitors May Predispose to KetoacidosisThe Journal of Clinical Endocrinology & Metabolism, 2015
- Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretionNature Medicine, 2015
- Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patientsJournal of Clinical Investigation, 2014
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose productionJournal of Clinical Investigation, 2014
- Effects of Glucagon on Lipolysis and Ketogenesis in Normal and Diabetic MenJournal of Clinical Investigation, 1974